Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials

Eitemau Tebyg

• Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
  gan: Durgam S, et al.
  Cyhoeddwyd: (2016-12-01)
• Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials
  gan: Thase, Michael E., et al.
  Cyhoeddwyd: (2017)
• Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials
  gan: Kornstein, Susan, et al.
  Cyhoeddwyd: (2018)
• Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial
  gan: Citrome, Leslie, et al.
  Cyhoeddwyd: (2015)
• Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
  gan: Durgam, Suresh, et al.
  Cyhoeddwyd: (2018)